NCT05036850Recruiting
China Kidney Patient Trials Network
Source: ClinicalTrials.gov · Last updated 6 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 27 Aug 2021
- Start date
- 27 Sept 2021
- Primary completion date
- 15 Sept 2026
- Lead sponsor
- George (Beijing) Clinical Research Co. Ltd.
- Diseases
- Chronic kidney disease, IgA nephropathy
- NCT number
- NCT05036850
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 27 Sept 2021 to the primary completion date, 15 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Life-expectancy of less than 6 months
Who the study is looking for
- Documented diagnosis of primary kidney disease
- Regular visits (at least 6 monthly) with a physician at a participating site
- eGFR \> 15 ml/min/1.73 m2
- ≥ 2 years of age
- Willing and able to sign informed consent
- Willing to be approached about participation in interventional research studies
Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| George Clinical (Beijing) Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.